Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0100
0.00 (0.00%)
At close: Jun 18, 2025

Diagonal Bio AB Revenue

Diagonal Bio AB had revenue of 483.00K SEK in the quarter ending March 31, 2025, with 93.20% growth. This brings the company's revenue in the last twelve months to 1.36M, down -42.72% year-over-year. In the year 2024, Diagonal Bio AB had annual revenue of 1.13M, down -64.30%.

Revenue (ttm)
1.36M
Revenue Growth
-42.72%
P/S Ratio
8.05
Revenue / Employee
339.50K
Employees
5
Market Cap
10.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.13M-2.03M-64.30%
Dec 31, 20233.15M-555.00K-14.98%
Dec 31, 20223.71M-4.96M-57.25%
Dec 31, 20218.67M672.67K8.41%
Dec 31, 20208.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.31B
Getinge AB 35.57B
Asker Healthcare Group AB 15.57B
Medicover AB 23.56B
Camurus AB 2.04B
AddLife AB 10.42B
Vimian Group AB 4.24B
Revenue Rankings